SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (17155)6/5/2003 10:57:42 AM
From: Jurgis Bekepuris  Respond to of 78748
 
Paul,

PFE. I have difficulty using ROE above 25% for any company as an expected "long term ROE". It just seems that almost everything above 25% or even 20% eventually crashes through the bottom. Using 25% ROE PFE is not a bargain with predicted annual return of 6.5%. Even with 30% ROE it would earn only ~12% (I buy at expected 15% return). Compare that to BMY which at current price and expected 20% ROE shows 9% expected return. Yes, I know that PFE is much better company, but how much better?

A related (?) story: I bought RTRSY at $17 and sold at $13 (now it's at $18 again). RTRSY had a ROE of 40-100% until the ROE crashed to 4.1% in 2001 and to losses last year. At the same time equity dropped from $1800M to $800M and expected return now even with 20% ROE (which is not guaranteed at all) is ~9%. Is it worth buying? Remember Mike Burry had a solid case of buying it in the 40's, 30's and all the way down. I know he's smart and uses stops, so he probably was not caught with a losing position. What I am trying to say is that these high ROE falling angels may be very dangerous if optimistic assumptions are used. I wonder if we are not still too optimistic about pharmas including PFE and BMY.

OTOH, I may have been too pessimistic about RTRSY. I don't know. Other opinions would be appreciated.

Jurgis - holding BMY, contemplating losing trade on RTRSY and whether it is worthwhile to reenter RTRSY at any point in the future.



To: Paul Senior who wrote (17155)6/6/2003 1:23:34 PM
From: Bob Rudd  Respond to of 78748
 
PFE "ROE is high all right, but book value to price is very low" Share buybacks lower book value thus raising ROE. I would suspect that's what's going on here, but haven't confirmed. I bought a couple of slices of PFE ~30.50 and continue to think it's attractive: as the top tier "class act" in big Pharms, it'll never be really cheap, but at these levels it's at least reasonable.